Minimal changes in the overall activity of SOD measured in the serum (SOD1 and SOD3) of the patients with endometriosis and endometrial cancer could be therefore caused by a similar Cu/Zn ratio in these groups as both elements are required for the activation of Cu/Zn SODs. The gene discussed is SOD3; the disease is endometrial cancer.